NATURE’S SUNSHINE PRODUCTS, INC. Operating Lease Right-of-Use Assets
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Operating Lease Right-of-Use Assets of $19.28 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $19.28M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $20.38M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $17.60M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $12.96M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $19.28M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $20.38M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $17.60M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $12.96M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $14.22M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $13.46M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $12.80M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $13.81M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $13.72M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $15.97M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $13.36M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $14.11M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $15.32M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $16.15M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $16.14M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $16.54M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $18.06M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $18.96M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $18.35M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $19.14M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $18.56M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $18.88M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $20.21M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $20.63M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $20.57M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $21.37M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $20.21M 10-K · filed 2022-03-08 | $23.95M 10-K · filed 2020-03-11 |
| 2019-09-30 | $24.89M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $26.36M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $21.78M 10-Q · filed 2019-05-09 | |
| 2019-01-01 | $23.10M 10-K · filed 2021-03-10 | |
| 2018-12-31 | $23.95M 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |